Brass Tax Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$605K Sell
13,405
-76
-0.6% -$3.55K 0.1% 107
2025
Q2
$624K Sell
13,481
-1,073
-7% -$52.7K 0.12% 91
2025
Q1
$888K Buy
14,554
+483
+3% +$28.2K 0.19% 61
2024
Q4
$796K Buy
14,071
+120
+0.9% +$6.71K 0.17% 66
2024
Q3
$722K Buy
13,951
+8,184
+142% +$384K 0.15% 69
2024
Q2
$239K Buy
+5,767
New +$258K 0.1% 120

Other funds holding BMY

Brass Tax Wealth Management's BMY Position: Q3 2025 in Review

Brass Tax Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.56% in Q3 2025, selling an estimated $3.55K and leaving 13,405 shares worth $605K. The position accounts for 0.1% of the portfolio, ranked #107.

Brass Tax Wealth Management first reported a position in BMY in Q2 2024 and has held it in 6 quarters since. The position peaked at $888K in Q1 2025. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Brass Tax Wealth Management held 13,405 shares of Bristol-Myers Squibb worth $605K as of Q3 2025.
  • Brass Tax Wealth Management sold 76 Bristol-Myers Squibb shares in Q3 2025, an estimated $3.55K.
  • Bristol-Myers Squibb made up 0.1% of Brass Tax Wealth Management's portfolio in Q3 2025, its #107 holding.
  • Brass Tax Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 6 quarters since.
  • Brass Tax Wealth Management's Bristol-Myers Squibb position peaked at $888K in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Brass Tax Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.